Strateos Revenue and Competitors
Estimated Revenue & Valuation
- Strateos's estimated annual revenue is currently $16.3M per year.
- Strateos's estimated revenue per employee is $155,000
Employee Data
- Strateos has 105 Employees.
- Strateos grew their employee count by -22% last year.
Strateos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Technology Enabling & Digital Transformation Services | Reveal Email/Phone |
2 | VP Product & Technology | Reveal Email/Phone |
3 | VP Science and Technology | Reveal Email/Phone |
4 | VP, Project Management Office | Reveal Email/Phone |
5 | VP People | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | Director Engineering, Software | Reveal Email/Phone |
8 | Director Business Development | Reveal Email/Phone |
9 | Director Lab Solutions | Reveal Email/Phone |
10 | Director Scientific Applications | Reveal Email/Phone |
Strateos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A | N/A |
What Is Strateos?
Strateos automates chemistry, biology, and tissue analysis into closed loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, we enable our pharmaceutical partners to more rapidly and efficiently discover new drug candidates. Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combines automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development.
keywords:N/A
N/A
Total Funding
105
Number of Employees
$16.3M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Strateos News
Strateos is a pioneer in the development of remote access laboratories and lab automation software for life science discovery. Our mission is to...
Strateos, a Menlo Park, CA-based company which specializes in development of remote access laboratories and lab control software for life science research, raised $56.1M in Series B funding. The round was led by DCVC and Lux Capital with participation from new investors including Eli Lilly and ...
Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, Al ...
3Scan, a San Francisco, CA-based computational pathology services platform, raised $14m in Series B financing. The round was led by existing investors Lux Capital and Data Collective, with participation from the investment arm of one of the top U.S. research hospitals, prior backer Dolby Family ...
Robots and software aren’t just changing manual labor in warehouses or kitchens. They’re also transforming medical research. A San Francisco startup called 3Scan Inc. raised $14 million in venture funding to automate tissue analysis for scientists involved in drug discovery with its proprietary ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.3M | 105 | 4% | $88M |
#2 | $16.4M | 106 | 6% | $206M |
#3 | $7.5M | 106 | 5% | N/A |
#4 | $15M | 108 | 21% | N/A |
#5 | $22.2M | 109 | 9% | $45.1M |